CLOV Clover Health Investments Corp
Price (delayed)
$3.47
Market cap
$1.77B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.09
Enterprise value
$1.58B
Clover Health is a healthcare technology company with a deeply rooted mission of improving every life. Clover uses its proprietary technology platform to collect, structure, and analyze health and behavioral
Highlights
The debt has plunged by 100% from the previous quarter
The net income has soared by 80% year-on-year and by 53% since the previous quarter
Clover Health Investments's quick ratio has increased by 11% YoY but it has decreased by 7% QoQ
Key stats
What are the main financial stats of CLOV
Market
Valuations
Earnings
Shares outstanding
510.91M
Market cap
$1.77B
Enterprise value
$1.58B
Price to earnings (P/E)
N/A
Price to book (P/B)
5.1
Price to sales (P/S)
1.24
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.15
Revenue
$1.37B
Gross profit
$364.8M
Operating income
-$45.75M
Net income
-$43.01M
EBIT
-$43.01M
EBITDA
-$41.68M
Free cash flow
$33.29M
Per share
Balance sheet
Liquidity
EPS
-$0.09
EPS diluted
-$0.09
Free cash flow per share
$0.07
Book value per share
$0.68
Revenue per share
$2.8
TBVPS
$1.18
Total assets
$580.74M
Total liabilities
$239.6M
Debt
$0
Equity
$341.14M
Working capital
$129.61M
Debt to equity
0
Current ratio
1.61
Quick ratio
1.28
Net debt/EBITDA
4.67
Margins
Efficiency
Dividend
EBITDA margin
-3%
Gross margin
26.6%
Net margin
-3.1%
Operating margin
-3.3%
Return on assets
-6.7%
Return on equity
-13.2%
Return on invested capital
-37.4%
Return on capital employed
-11.7%
Return on sales
-3.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CLOV stock price
How has the Clover Health Investments stock price performed over time
Intraday
1.17%
1 week
4.52%
1 month
-3.34%
1 year
410.29%
YTD
10.16%
QTD
-3.34%
Financial performance
How have Clover Health Investments's revenue and profit performed over time
Revenue
$1.37B
Gross profit
$364.8M
Operating income
-$45.75M
Net income
-$43.01M
Gross margin
26.6%
Net margin
-3.1%
The net margin has soared by 82% YoY and by 54% from the previous quarter
The net income has soared by 80% year-on-year and by 53% since the previous quarter
Clover Health Investments's operating margin has soared by 80% YoY and by 49% from the previous quarter
The operating income has soared by 78% YoY and by 48% from the previous quarter
Growth
What is Clover Health Investments's growth rate over time
Valuation
What is Clover Health Investments stock price valuation
P/E
N/A
P/B
5.1
P/S
1.24
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.15
CLOV's EPS has surged by 80% year-on-year and by 55% since the previous quarter
The P/B is 70% below the 5-year quarterly average of 17.2 but 70% above the last 4 quarters average of 3.0
The equity has grown by 19% YoY
The P/S is 77% above the last 4 quarters average of 0.7 but 56% below the 5-year quarterly average of 2.8
The revenue has grown by 9% YoY
Efficiency
How efficient is Clover Health Investments business performance
The return on invested capital has surged by 83% year-on-year and by 51% since the previous quarter
CLOV's return on sales has surged by 82% year-on-year and by 54% since the previous quarter
CLOV's ROE has soared by 80% YoY and by 55% from the previous quarter
The ROA has soared by 66% YoY and by 53% from the previous quarter
Dividends
What is CLOV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CLOV.
Financial health
How did Clover Health Investments financials performed over time
CLOV's total assets is 142% greater than its total liabilities
Clover Health Investments's total liabilities has decreased by 23% from the previous quarter and by 16% YoY
CLOV's total assets is down by 11% since the previous quarter
The debt is 100% less than the equity
The debt to equity has plunged by 100% from the previous quarter
The debt has plunged by 100% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.